| SBRT | Stereotactic body radiotherapy |
| SABR | Stereotactic ablative radiotherapy |
| LC | Local control |
| BED | Biologically effective dose |
| OS | Overall survival |
| FB | Free breathing |
| ITV | Internal tumour volume |
| BH | Breath hold |
| CTV | Clinical target volume |
| PTV | Planning target volume |
| MRI | Magnetic resonance imaging |
| LAPC | Locally advanced pancreatic cancer |
| TIVA | Total intravenous anaesthesia |
| ACMV | Assist-control mechanical ventilation |
| OSG | Optical surface guidance |
| OAR | Organs at risk |
| ECOG PS | Eastern Cooperative Oncology Group Performance Status |
| MDT | Multidisciplinary team |
| NCCN | National Comprehensive Cancer Network |
| MSCT | Multi-slice computed tomography |
| PET/CT | Positron emission tomography/computed tomography |
| ASA | American Society of Anaesthesiology |
| NIPB | Non-invasive blood pressure |
| IBP | Invasive arterial pressure |
| CBCT | Cone beam CT |
| IG | Image guidance |
| DBC | Default body contour |
| ROI | Region of interest |
| GTV | Gross tumour volume |
| ESTRO | European Society for Radiotherapy and Oncology |
| ASTRO | American Society for Radiation Oncology |
| SIB | Simultaneous integrated boost |
| NCI | National Cancer Institute |
| CTCAE | Common Terminology Criteria for Adverse Events |
| FFLP | Freedom from local progression |
| PFS | Progression-free survival |
| CI | Confidence interval |
| GI | Gastrointestinal |